Kindbody Raises $32 Million in Series B Funding to Grow Employer Benefits Solution and Fuel U.S. Expansion

NEW YORK, July 8, 2020 /PRNewswire/ — Kindbody, a fast growing health and technology company providing fertility, gynecology, and family-building care, today announced $32 million in Series B funding, bringing its total amount raised to $64 million.

Kindbody offers end-to-end services from preconception through postpartum, serving as both a provider and network solution. Their offering covers fertility treatment, including IVF and egg freezing, as well as gynecology, wellness, and LGBTQ+ services. Their approach features direct purchasing and inclusive bundled-rates, which allows Kindbody to offer pricing up to 30% less than other fertility benefit programs.

The Series B round was led by Perceptive Advisors, with participation from existing investors RRE, GV (formerly Google Ventures), and Freemark Capital. New investors include major private and public healthcare funds Rock Springs Capital, Goodgrower and Claritas Capital as well as benefits consulting firm, NFP. The funds will be used to expand Kindbody’s national footprint and build an international presence, through brick-and-mortar locations and a growing “Center of Excellence” (COE) network of partner clinics.

Kindbody leverages proprietary technology to deliver a seamless member experience and data-driven results at its 180+ Kindbody and COE locations. The Company works with employers as a full-service benefits solution to deliver a premium experience with significant costs savings, and directly with patients, as an accessible, inclusive provider.

“You must be in the provision of services – in the actual care delivery business – to effectuate change in member experience, outcomes and costs. Sophisticated employers know this and are helping to drive change, utilizing their buying power to control costs. We’re fortunate to have blue-chip investors to help accelerate this,” said Founder and CEO, Gina Bartasi. Adding, “The funds allow us to scale the infrastructure – in terms of people and process – required to execute on large accounts. We’re adding depth to our outstanding team at almost every level.”

“We’ve followed Gina’s career since her time at Progyny and trust her veteran leadership to not only navigate through the global pandemic, but show tremendous growth. June’s patient volume is up 30% from pre-Covid levels – which speaks to the resilience of the business, and the interest from employers, which we see as a huge opportunity going forward,” said Ellen Hukkelhoven, Managing Director, Perceptive Advisors.

Kindbody’s clinical team is led by Chief Medical Officer, Dr. Lynn Westphal, the former head of Stanford Medicine’s Third-Party and Fertility Preservation Program, and Founding Ob/Gyn, Dr. Fahimeh Sasan, previously at Mount Sinai. Their corporate team includes President Annbeth Eschbach, Chief Operating Officer Patty Stull, Chief Business and Legal Officer, Shilpa Patel and Chief Financial Officer, Debbie Markowitz.

About Kindbody
Kindbody provides fertility, gynecology, and family-building services at Kindbody clinics and a network of high quality partner clinics. As both a provider and network solution, Kindbody serves patients and employers at 180+ locations, leveraging proprietary technology to deliver a seamless end-to-end experience. Kindbody offers superior outcomes at significantly lower prices, with a mission to increase access to care and deliver a more welcoming, inclusive experience.

Media Inquiries:
Rebecca Silver, Vice President, Brand Marketing
rebecca.silver@kindbody.com
1-855-563-2639

View original content to download multimedia:http://www.prnewswire.com/news-releases/kindbody-raises-32-million-in-series-b-funding-to-grow-employer-benefits-solution-and-fuel-us-expansion-301090458.html

SOURCE Kindbody

Staff

Recent Posts

Universal Brain Announces Publication of Groundbreaking Depression Research Using Multiple Event-Related Potentials

New findings support the company's neuroscience-driven approach to precision psychiatry, offering actionable insights for personalized…

5 hours ago

Iktos and Cube Biotech Announce Launch of Small Molecule AI Drug Discovery Collaboration

Partnership will leverage Iktos's AI-enabled drug discovery platform and Cube Biotech's advanced protein technologies to…

5 hours ago

MimiVax and UI Pharmaceuticals Achieve Milestone in SurVaxM Production for Glioblastoma Treatment

SurVaxM is the first drug product to be produced in UI Pharmaceuticals new facilityUI Pharmaceuticals…

5 hours ago

RingConn Takes Center Stage at CES 2025 with Innovative Wearables: Gen 2 and Gen 2 Air

LAS VEGAS, Jan. 10, 2025 /PRNewswire/ -- RingConn, a leading smart wearable brand, is proud…

5 hours ago

1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly Report and Announces Management Changes

VANCOUVER, BC / ACCESSWIRE / January 10, 2025 / 1933 Industries Inc. (the "Company" or…

5 hours ago